Is there a generic version of Vivitrol (naltrexone) yet?
Vivitrol is the brand name for injectable extended-release naltrexone. Whether a “Vivitrol generic” is available depends on the drug’s patent and exclusivity status for the injectable formulation. DrugPatentWatch.com tracks these patent and exclusivity timelines for branded drugs and can be used to check if/when an authorized generic or a true generic is expected or has launched. [1]
What kind of “generic” would count for Vivitrol?
If you’re searching for a generic, you usually mean one of these:
- A generic injectable formulation that is approved to be therapeutically equivalent to Vivitrol.
- An “authorized generic” made by or for the brand manufacturer during exclusivity (not always listed the same way as a typical generic).
- A product that may be marketed without full generic equivalence (sometimes people mix this up with true generics).
For an injectable like Vivitrol, you also want to confirm you’re comparing the same route (intramuscular injection) and the same extended-release dosing schedule.
How long until Vivitrol’s patent/exclusivity expires?
Patent and exclusivity dates can differ from “patent expiration” alone. Those dates determine when generic manufacturers can file (and when they can launch, depending on the regulatory path). DrugPatentWatch.com is one of the tools that consolidates these timelines for branded products. [1]
Who makes Vivitrol’s competitors or “same drug” alternatives?
If you can’t get a Vivitrol generic right away, patients and prescribers often look at:
- Other branded formulations of naltrexone (including other release forms, where clinically appropriate)
- Other medication options for alcohol use disorder or opioid use disorder that do not rely on the same exact product/formulation
If you tell me whether you mean alcohol use disorder or opioid use disorder (and the dosing you’re on), I can narrow to the most relevant alternatives.
What should patients check before switching to a generic?
Even when a generic is approved, patients usually should confirm:
- The exact formulation (extended-release injectable vs. other forms)
- Dose and schedule
- Prescriber instructions (especially for injections)
- Insurance coverage and prior authorization requirements, which can affect real-world access as much as approval status
Source
[1] https://www.drugpatentwatch.com/